Cargando…

Potential for false decline of anti-SARS-CoV-2 spike antibody titers after COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Waldman, Meryl, Sacks, David B, Howard, Lilian, Cole, Justine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411255/ https://www.ncbi.nlm.nih.gov/pubmed/36042969 http://dx.doi.org/10.1016/S2665-9913(22)00222-3

Ejemplares similares

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
por: Prasad, Mukul, et al.
Publicado: (2021)

Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron
por: Adachi, Eisuke, et al.
Publicado: (2022)

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals
por: Grunau, Brian, et al.
Publicado: (2022)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
por: Yamayoshi, Seiya, et al.
Publicado: (2021)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma
por: Salazar, Eric, et al.
Publicado: (2020)

Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2
por: Bi, Xiuqiong, et al.
Publicado: (2022)

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
por: Arora, Prerna, et al.
Publicado: (2021)

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
por: Li, Yang, et al.
Publicado: (2020)

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation
por: Capoferri, Gioele, et al.
Publicado: (2023)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Lichen Planus in Silicosis Patient with Unusually High Antinuclear Antibody Titer
por: Gupta, Isha, et al.
Publicado: (2017)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis
por: Türkoğlu, Recai, et al.
Publicado: (2022)

Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein–ACE2 interaction
por: Yuan, MengYa, et al.
Publicado: (2021)

Influencing factors of anti‐SARS‐CoV‐2‐spike‐IgG antibody titers in healthcare workers: A cross‐section study
por: Reusch, Julia, et al.
Publicado: (2022)

Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents
por: Dyer, Adam H., et al.
Publicado: (2022)

Clinical characteristics and plasma antibody titer of patients with COVID-19 in Zhejiang, China
por: Xiang, Wei-ling, et al.
Publicado: (2020)

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
por: Chen, Xiangyu, et al.
Publicado: (2020)

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
por: Chen, Shiqi, et al.
Publicado: (2023)

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
por: He, Yuxian, et al.
Publicado: (2004)

Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
por: Jo, Dong-Ho, et al.
Publicado: (2021)

High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV
por: Sasaki, Hiroaki, et al.
Publicado: (2022)

Associations of HLA Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with BNT162b2
por: Higuchi, Takashi, et al.
Publicado: (2023)

Anti‐SARS‐CoV‐2 spike immunoglobulin G and immunoglobulin M titers decline as interval from the second inactivated vaccine dose to the onset of illness is prolonged in breakthrough infection patients
por: Xu, Chuan‐cai, et al.
Publicado: (2023)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Setting-specific variability of false-positive result rates with rapid testing for SARS-CoV-2 antigen
por: Posteraro, Patrizia, et al.
Publicado: (2022)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
por: Antonelli, Guido, et al.
Publicado: (2021)

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Tada, Takuya, et al.
Publicado: (2021)

Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination Regimes
por: Odainic, Alexandru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4l9et0n014lvleh3mrcmlo43ha